Serviços farmacêuticos voltados à alta hospitalar: potencialidades, limitações e estratégias para otimizar resultados
##plugins.themes.bootstrap3.article.sidebar##
Publicado
Mar 16, 2025
##plugins.themes.bootstrap3.article.main##
Resumo
Objetivo: Discutir as potencialidades e limitações dos serviços farmacêuticos voltados à transição hospital-domicílio e estratégias para otimizar resultados. Revisão bibliográfica: Boas práticas no cuidado voltadas à alta hospitalar são importantes para evitar agravos aos pacientes e reincidência de internação decorrentes de problemas relacionados à farmacoterapia. Todavia, a implementação e execução de serviços clínicos direcionados à transição hospital-domicílio abrangem questões complexas que envolvem a disponibilidade de recursos humanos, colaboração interprofissional, alinhamento entre fluxos de trabalho e adequações às necessidades e particularidades das unidades de internação onde as ações do cuidado estão sendo praticadas. A integração planejada e estruturada de diferentes serviços farmacêuticos possibilita organizá-los numa disposição que oportunize acentuar as potencialidades da prática isolada de cada serviço e amenizar suas limitações, representando assim uma boa alternativa para otimizar os resultados do cuidado praticado na transição hospital-domicílio. Considerações finais: Esta abordagem visa a ampliar a discussão referente à integração de serviços farmacêuticos no cuidado voltado à alta hospitalar.
##plugins.themes.bootstrap3.article.details##
Como Citar
RibeiroL. C., FragosoM. de C., & AndradeT. U. de. (2025). Serviços farmacêuticos voltados à alta hospitalar: potencialidades, limitações e estratégias para otimizar resultados. Revista Eletrônica Acervo Saúde, 25, e18866. https://doi.org/10.25248/reas.e18866.2025
Seção
Revisão Bibliográfica
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Referências
1. AL ABD BM, et al. Impact of Clinical Pharmacists-driven Bundled Activities from Admission to Discharge on 90-day Hospital Readmissions and Emergency Department Visits. Oman medical journal, 2023; 38(6): 566.
2. ANTIMICROBIAL RESISTANCE COLLABORATORS. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet (London, England), 2022; 399(10325): 629–655.
3. BORBA HHL e CARVALHO DMW. Impact of the Fourth Industrial Revolution on clinical pharmaceutical services: A scoping review. Research in social & administrative pharmacy, 2023; 19 (2): 235–242.
4. BRASIL. Ministério da Saúde. Cuidado Farmacêutico na Atenção Básica: capacitação para a implantação dos Serviços de Clínica Farmacêutica. Brasília, 2015; 2: 109.
5. BRASIL. Ministério da Saúde. Lista de Medicamentos Essenciais, 2022. Disponível em: https ://www.conass.org.br/wp-content/uploads/2022/01/RENAME-2022.pdf. Acessado em: 17 de maio de 2024.
6. BRASIL. Segurança na prescrição, uso e administração de medicamentos. Ministério da Saúde. 2023.
Disponível em: https ://www.gov.br/saude/pt-br/composicao/saes/dahu/pnsp/protocolos-basicos/protocol o-seguraca-na-prescricao-uso-e-administracao-de-medicamentos.pdf/view. Acessado em: 19 de março 2024.
7. CAPIAU A, et al. Medication Counselling in Older Patients Prior to Hospital Discharge: A Systematic Review. Drugs & aging, 2020; 37(9): 635–655.
8. CFF. Serviços farmacêuticos diretamente destinados ao paciente, à família e à comunidade: contextualização e arcabouço conceitual, 2016. Disponível em: https ://www.cff.org.br/userfiles/Profar_ Arcabouco_TELA_FINAL.pdf. Acessado em 12 de julho de 2024.
9. CHRISTIANSEN SR, et al. Impact of a prescription review program on the accuracy and safety of discharge prescriptions in a pediatric hospital setting. The journal of pediatric pharmacology and therapeutics, 2008; 13(4): 226-232.
10. CORREARD F, et al. Conciliation médicamenteuse: intérêts et limites. La Revue de medecine interne, 2023; 44 (9): 479-486.
11. COSTELLO J, et al. The impact of hospital-based post-discharge pharmacist medication review on patient clinical outcomes: A systematic review. Exploratory research in clinical and social pharmacy, 2023; 11: 100305.
12. DÁDER MJF, et al. Atenção farmacêutica: serviços farmacêuticos orientados ao paciente. São Paulo: RCN Editora, 2019; 360.
13. DALIRI S, et al. Barriers and facilitators with medication use during the transition from hospital to home: a qualitative study among patients. BMC Health Services Research, 2019; 19(204): 1-8.
14. DALIRI S, et al. Longitudinal medication reconciliation at hospital admission, discharge and post-discharge. Research in Social Administrative Pharmacy, 2021; 17(4): 677-684.
15. DHARMAR M, et al. Telemedicine consultations and medication errors in rural emergency departments. Pediatrics, 2013; 132(6): 1090–1097.
16. ENSING HT, et al. Identifying the Optimal Role for Pharmacists in Care Transitions: A Systematic Review. Journal of managed care & specialty pharmacy, 2015; 21(8): 614-36.
17. FELDMANN JD, et al. A community pharmacist-led service to facilitate care transitions and reduce hospital readmissions. Journal of the American Pharmacists Association, 2018; 58(1): 36–43.
18. FENG LY, et al. Comparison of legislative management for new psychoactive substances control among Taiwan, South Korea, and Japan. The Kaohsiung journal of medical sciences, 2020; 36(2): 135-142.
19. FERNANDES BD, et al. Medication Reconciliation at hospital admission and discharge: Evaluation of fidelity and process outcomes in a real-world setting. The International Journal clinical practice, 2021; 75 (10): 14656.
20. HOLDFORD DA. Perspectives on the pharmacist's "product": a narrative review. Pharmacy practice, 2021; 19(2): 1-9.
21. HOVEY SW, et al. Pharmacist-Led Discharge Transitions of Care Interventions for Pediatric Patients: A Narrative Review. The journal of pediatric pharmacology and therapeutics, 2023; 28(3): 180-191.
22. JONES AR, et al. Bone health in rural Australia: a mixed methods study of consumer needs. Archives of osteoporosis, 2023; 1(1): 127.
23. KATZ DT, et al. Timely Delivery of Discharge Medications to Patients' Bedsides: A Patient-centered Quality Improvement Project. Pediatric quality & safety, 2020; 5(3): 297.
24. PARSELS KA, et al. Hospital Discharge: An Opportune Time for Antimicrobial Stewardship. The Annals of pharmacotherapy, 2022; 56(8): 869–877.
25. PEVNICK JM, et al. Tools and tactics for postdischarge medication management interventions. American journal of health-system pharmacy, 2021; 78(7): 619-632.
26. RIBEIRO LC. A importância do cuidado farmacêutico na prevenção e tratamento de doenças cardiovasculares. Revista Eletrônica Acervo Saúde, 2020; 57: 4058.
27. ROHDE LEP, et al. Diretriz brasileira de insuficiência cardíaca crônica e aguda. Arquivos Brasileiros de Cardiologia, 2018; 111(3): 436-539.
28. SIEGEL J, et al. A feasibility pilot using a mobile personal health assistant (PHA) app to assist stroke patient and caregiver communication after hospital discharge. MHealth, 2016; 2(31): 1-5.
29. SPIGELMYER A, et al. Impact of clinical pharmacist discharge prescription review on the appropriateness of antibiotic therapy: a retrospective comparison. International Journal of Clinical Pharmacy, 2023; 45(3): 769–773.
30. STOLL JT e WEIDMANN AE. Development of hospital pharmacy services at transition of care points: a scoping review. European journal of hospital pharmacy: science and practice, 2024.
31. TAIT LA, et al. Medication supply at hospital discharge via community pharmacy: a quality improvement study. International Journal of Clinical Pharmacy, 2023; 45(6): 1309–1316.
32. TANG KWK, et al. Antimicrobial Resistance (AMR). British journal of biomedical Science, 2023; 80 (11387): 1-11.
33. THAKKAR J, et al. Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis. JAMA internal medicine, 2016; 176(3): 340-349.
34. URBANCZYK K, et al. Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes. Frontiers in Pharmacology, 2023.
35. VRANKEN MJM, et al. Barriers to access to opioid medicines: a review of national legislation and regulations of 11 central and eastern European countries. The Lancet. Oncology, 2016; 17(1): 13-22.
36. WEEDA E, et al. Impact of Pharmacist-Driven Transitions of Care Interventions on Post-hospital Outcomes Among Patients With Coronary Artery Disease: A Systematic Review. Journal of pharmacy practice, 2023; 36(3): 668–678.
37. WHO. Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2022, 2022. Disponível em: https ://iris.who.int/bitstream/handle/10665/364996/9789240062702-eng.pdf?Sequence= 1. Acessado em 16 de maio de 2024.
38. WHO. Global Patient Safety Action Plan 2021-2030: Towards eliminating avoidable harm in health care, 2021. Disponível em: https ://www.who.int/publications/i/item/9789240032705. Acessado em 06 de maio de 2024.
39. WHO. Global Patient Safety Challenge: Medication Without Harm, 2017. Disponível em: https ://www.who.int/publications/i/item/WHO-HIS-SDS-2017.6. Acessado em: 11 de julho de 2024.
40. WHO. Medication Safety in Transitions of Care, 2019. Disponível em: https ://iris.who.int/bitstream/ handle/10665/325453/WHO-UHC-SDS-2019.9-eng.pdf?sequence=1. Acessado em 10 de maio de 2024.
2. ANTIMICROBIAL RESISTANCE COLLABORATORS. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet (London, England), 2022; 399(10325): 629–655.
3. BORBA HHL e CARVALHO DMW. Impact of the Fourth Industrial Revolution on clinical pharmaceutical services: A scoping review. Research in social & administrative pharmacy, 2023; 19 (2): 235–242.
4. BRASIL. Ministério da Saúde. Cuidado Farmacêutico na Atenção Básica: capacitação para a implantação dos Serviços de Clínica Farmacêutica. Brasília, 2015; 2: 109.
5. BRASIL. Ministério da Saúde. Lista de Medicamentos Essenciais, 2022. Disponível em: https ://www.conass.org.br/wp-content/uploads/2022/01/RENAME-2022.pdf. Acessado em: 17 de maio de 2024.
6. BRASIL. Segurança na prescrição, uso e administração de medicamentos. Ministério da Saúde. 2023.
Disponível em: https ://www.gov.br/saude/pt-br/composicao/saes/dahu/pnsp/protocolos-basicos/protocol o-seguraca-na-prescricao-uso-e-administracao-de-medicamentos.pdf/view. Acessado em: 19 de março 2024.
7. CAPIAU A, et al. Medication Counselling in Older Patients Prior to Hospital Discharge: A Systematic Review. Drugs & aging, 2020; 37(9): 635–655.
8. CFF. Serviços farmacêuticos diretamente destinados ao paciente, à família e à comunidade: contextualização e arcabouço conceitual, 2016. Disponível em: https ://www.cff.org.br/userfiles/Profar_ Arcabouco_TELA_FINAL.pdf. Acessado em 12 de julho de 2024.
9. CHRISTIANSEN SR, et al. Impact of a prescription review program on the accuracy and safety of discharge prescriptions in a pediatric hospital setting. The journal of pediatric pharmacology and therapeutics, 2008; 13(4): 226-232.
10. CORREARD F, et al. Conciliation médicamenteuse: intérêts et limites. La Revue de medecine interne, 2023; 44 (9): 479-486.
11. COSTELLO J, et al. The impact of hospital-based post-discharge pharmacist medication review on patient clinical outcomes: A systematic review. Exploratory research in clinical and social pharmacy, 2023; 11: 100305.
12. DÁDER MJF, et al. Atenção farmacêutica: serviços farmacêuticos orientados ao paciente. São Paulo: RCN Editora, 2019; 360.
13. DALIRI S, et al. Barriers and facilitators with medication use during the transition from hospital to home: a qualitative study among patients. BMC Health Services Research, 2019; 19(204): 1-8.
14. DALIRI S, et al. Longitudinal medication reconciliation at hospital admission, discharge and post-discharge. Research in Social Administrative Pharmacy, 2021; 17(4): 677-684.
15. DHARMAR M, et al. Telemedicine consultations and medication errors in rural emergency departments. Pediatrics, 2013; 132(6): 1090–1097.
16. ENSING HT, et al. Identifying the Optimal Role for Pharmacists in Care Transitions: A Systematic Review. Journal of managed care & specialty pharmacy, 2015; 21(8): 614-36.
17. FELDMANN JD, et al. A community pharmacist-led service to facilitate care transitions and reduce hospital readmissions. Journal of the American Pharmacists Association, 2018; 58(1): 36–43.
18. FENG LY, et al. Comparison of legislative management for new psychoactive substances control among Taiwan, South Korea, and Japan. The Kaohsiung journal of medical sciences, 2020; 36(2): 135-142.
19. FERNANDES BD, et al. Medication Reconciliation at hospital admission and discharge: Evaluation of fidelity and process outcomes in a real-world setting. The International Journal clinical practice, 2021; 75 (10): 14656.
20. HOLDFORD DA. Perspectives on the pharmacist's "product": a narrative review. Pharmacy practice, 2021; 19(2): 1-9.
21. HOVEY SW, et al. Pharmacist-Led Discharge Transitions of Care Interventions for Pediatric Patients: A Narrative Review. The journal of pediatric pharmacology and therapeutics, 2023; 28(3): 180-191.
22. JONES AR, et al. Bone health in rural Australia: a mixed methods study of consumer needs. Archives of osteoporosis, 2023; 1(1): 127.
23. KATZ DT, et al. Timely Delivery of Discharge Medications to Patients' Bedsides: A Patient-centered Quality Improvement Project. Pediatric quality & safety, 2020; 5(3): 297.
24. PARSELS KA, et al. Hospital Discharge: An Opportune Time for Antimicrobial Stewardship. The Annals of pharmacotherapy, 2022; 56(8): 869–877.
25. PEVNICK JM, et al. Tools and tactics for postdischarge medication management interventions. American journal of health-system pharmacy, 2021; 78(7): 619-632.
26. RIBEIRO LC. A importância do cuidado farmacêutico na prevenção e tratamento de doenças cardiovasculares. Revista Eletrônica Acervo Saúde, 2020; 57: 4058.
27. ROHDE LEP, et al. Diretriz brasileira de insuficiência cardíaca crônica e aguda. Arquivos Brasileiros de Cardiologia, 2018; 111(3): 436-539.
28. SIEGEL J, et al. A feasibility pilot using a mobile personal health assistant (PHA) app to assist stroke patient and caregiver communication after hospital discharge. MHealth, 2016; 2(31): 1-5.
29. SPIGELMYER A, et al. Impact of clinical pharmacist discharge prescription review on the appropriateness of antibiotic therapy: a retrospective comparison. International Journal of Clinical Pharmacy, 2023; 45(3): 769–773.
30. STOLL JT e WEIDMANN AE. Development of hospital pharmacy services at transition of care points: a scoping review. European journal of hospital pharmacy: science and practice, 2024.
31. TAIT LA, et al. Medication supply at hospital discharge via community pharmacy: a quality improvement study. International Journal of Clinical Pharmacy, 2023; 45(6): 1309–1316.
32. TANG KWK, et al. Antimicrobial Resistance (AMR). British journal of biomedical Science, 2023; 80 (11387): 1-11.
33. THAKKAR J, et al. Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis. JAMA internal medicine, 2016; 176(3): 340-349.
34. URBANCZYK K, et al. Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes. Frontiers in Pharmacology, 2023.
35. VRANKEN MJM, et al. Barriers to access to opioid medicines: a review of national legislation and regulations of 11 central and eastern European countries. The Lancet. Oncology, 2016; 17(1): 13-22.
36. WEEDA E, et al. Impact of Pharmacist-Driven Transitions of Care Interventions on Post-hospital Outcomes Among Patients With Coronary Artery Disease: A Systematic Review. Journal of pharmacy practice, 2023; 36(3): 668–678.
37. WHO. Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2022, 2022. Disponível em: https ://iris.who.int/bitstream/handle/10665/364996/9789240062702-eng.pdf?Sequence= 1. Acessado em 16 de maio de 2024.
38. WHO. Global Patient Safety Action Plan 2021-2030: Towards eliminating avoidable harm in health care, 2021. Disponível em: https ://www.who.int/publications/i/item/9789240032705. Acessado em 06 de maio de 2024.
39. WHO. Global Patient Safety Challenge: Medication Without Harm, 2017. Disponível em: https ://www.who.int/publications/i/item/WHO-HIS-SDS-2017.6. Acessado em: 11 de julho de 2024.
40. WHO. Medication Safety in Transitions of Care, 2019. Disponível em: https ://iris.who.int/bitstream/ handle/10665/325453/WHO-UHC-SDS-2019.9-eng.pdf?sequence=1. Acessado em 10 de maio de 2024.